Insigneo Advisory Services’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.7K Hold
10,000
– – ﹤0.01% 813
2026
Q2
$98.2K Hold
10,000
– – ﹤0.01% 816
2026
Q1
$84.7K Buy
+10,000
New +$95.3K 0.01% 678

Other funds holding OCUL

Insigneo Advisory Services's OCUL Position: Q3 2026 in Review

Insigneo Advisory Services held its Ocular Therapeutix (OCUL) position steady in Q3 2026 at 10,000 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Insigneo Advisory Services first reported a position in OCUL in Q1 2026 and has held it in 3 quarters since. The position peaked at $98.2K in Q2 2026. 258 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Insigneo Advisory Services held 10,000 shares of Ocular Therapeutix worth $76.7K as of Q3 2026.
  • Insigneo Advisory Services left its Ocular Therapeutix share count unchanged in Q3 2026.
  • Ocular Therapeutix made up ﹤0.01% of Insigneo Advisory Services's portfolio in Q3 2026, its #813 holding.
  • Insigneo Advisory Services first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 3 quarters since.
  • Insigneo Advisory Services's Ocular Therapeutix position peaked at $98.2K in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Insigneo Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.